A second scRNAseq dataset, based on T cell samples isolated from the blood, tumor tissue, and healthy adjacent tissue from treatment-naïve NSCLC patients was used to further evaluate GPR56 mRNA expression in the TIL repertoire. The gene discussed is ADGRG1; the disease is non-small cell lung carcinoma.